SeaStar Medical Stock More Than Doubles in 2 Days

Dow Jones2023-10-20

Shares of SeaStar Medical Holding Corp. rocketed 54.35% on heavy volume Thursday, taking them back above the $1 mark for the first time in five months.

The Colorado-based medical devices company’s stock has more than doubled in two days, as it ran up a record 70.1% on record volume of 179.5 million shares on Wednesday after the U.S. Food and Drug Administration granted breakthrough device designation for the company’s device used with patients in intensive care units with acute kidney injury and chronic liver failure.

SeaStar Medical has received breakthrough device designation from the FDA for its Selective Cytopheretic Device for the treatment of ICU patients with hepatorenal syndrome.

The device is being tested as a treatment for acute kidney injury in patients with chronic liver failure so that they may regain enough kidney function to be considered for a liver transplant.

SeaStar has been developing SCD as a treatment for hyperinflammation, known as cytokine storm, a life-threatening condition that can develop when the body's immune system responds too aggressively to injury or infection, such as acute kidney injury.

Sea Star went public in 2022 through a SPAC merger with LMF Acquisitions Opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

3

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2376528078?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-10-20 10:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2376528078","market":"us","top_or_hot":-1,"title":"SeaStar Medical Stock More Than Doubles in 2 Days","media":"Dow Jones","content":"<html><head></head><body><p>Shares of <a href=\"https://laohu8.com/S/ICU\">SeaStar Medical Holding Corp.</a> rocketed 54.35% on heavy volume Thursday, taking them back above the $1 mark for the first time in five months. </p><p>The Colorado-based medical devices company’s stock has more than doubled in two days, as it ran up a record 70.1% on record volume of 179.5 million shares on Wednesday after the U.S. Food and Drug Administration granted breakthrough device designation for the company’s device used with patients in intensive care units with acute kidney injury and chronic liver failure.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7842c5e2f697610f0883b1406246a9b3\" tg-width=\"825\" tg-height=\"634\"/></p><p>SeaStar Medical has received breakthrough device designation from the FDA for its Selective Cytopheretic Device for the treatment of ICU patients with hepatorenal syndrome.</p><p>The device is being tested as a treatment for acute kidney injury in patients with chronic liver failure so that they may regain enough kidney function to be considered for a liver transplant.</p><p>SeaStar has been developing SCD as a treatment for hyperinflammation, known as cytokine storm, a life-threatening condition that can develop when the body&#39;s immune system responds too aggressively to injury or infection, such as acute kidney injury.</p><p>Sea Star went public in 2022 through a SPAC merger with LMF Acquisitions Opportunities.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SeaStar Medical Stock More Than Doubles in 2 Days</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSeaStar Medical Stock More Than Doubles in 2 Days\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-20 10:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/seastar-medicals-stock-more-than-doubles-in-2-days-to-get-back-above-the-1-level-3e9f9dc0?mod=newsviewer_click><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of SeaStar Medical Holding Corp. rocketed 54.35% on heavy volume Thursday, taking them back above the $1 mark for the first time in five months. The Colorado-based medical devices company’s ...</p>\n\n<a href=\"https://www.marketwatch.com/story/seastar-medicals-stock-more-than-doubles-in-2-days-to-get-back-above-the-1-level-3e9f9dc0?mod=newsviewer_click\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICU","symbol_name":"SeaStar Medical Holding Corporation","start_time":0,"source_url":"https://www.marketwatch.com/story/seastar-medicals-stock-more-than-doubles-in-2-days-to-get-back-above-the-1-level-3e9f9dc0?mod=newsviewer_click","article_id":"2376528078","we_media_id":"1012688067","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2376528078","pubTimestamp":1697767421,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":1,"id":"1012688067","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of $SeaStar Medical Holding Corp.$ rocketed 54.35% on heavy volume Thursday, taking them back above the $1 mark for the first time in five months. The Colorado-based medical devices company’s stock has more than doubled in two days, as it ran up a record 70.1% on record volume of 179.5 million shares on Wednesday after the U.S. Food and Drug Administration granted breakthrough device designation for the company’s device used with patients in intensive care units with acute kidney injury a","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ICU":"SeaStar Medical Holding Corporation"},"translate_title":"海星医疗股票在两天内翻了一倍多","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICU":1.1},"content_text":"Shares of SeaStar Medical Holding Corp. rocketed 54.35% on heavy volume Thursday, taking them back above the $1 mark for the first time in five months. The Colorado-based medical devices company’s stock has more than doubled in two days, as it ran up a record 70.1% on record volume of 179.5 million shares on Wednesday after the U.S. Food and Drug Administration granted breakthrough device designation for the company’s device used with patients in intensive care units with acute kidney injury and chronic liver failure.SeaStar Medical has received breakthrough device designation from the FDA for its Selective Cytopheretic Device for the treatment of ICU patients with hepatorenal syndrome.The device is being tested as a treatment for acute kidney injury in patients with chronic liver failure so that they may regain enough kidney function to be considered for a liver transplant.SeaStar has been developing SCD as a treatment for hyperinflammation, known as cytokine storm, a life-threatening condition that can develop when the body's immune system responds too aggressively to injury or infection, such as acute kidney injury.Sea Star went public in 2022 through a SPAC merger with LMF Acquisitions Opportunities.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2376528078"}